Back

Neprilysin inhibition.

30 April 2017 (08:30 - 08:48)
Organised by:
Congress Presentation Part of: Novel drugs: how do they work? Diuretics HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Nicolas Vodovar

National Institute of Health and Medical Research (INSERM home), Paris (France)

4 More presentations in this session

Presentation thumbnail
Empaglifozin (SGLT-2 inhibition).
Professor N. Marx (Aachen, DE)
Slides Video
Presentation thumbnail
Serelaxin
Professor J. Teerlink (San Francisco, US)
Slides Video
Presentation thumbnail
Potassium binders.
Professor B. Pitt (Ann Arbor, US)
Slides Video
Presentation thumbnail
Beta-3 Agonists.
Professor J. Balligand (Brussels, BE)
Slides Video

Access the full session

Session thumbnail
Novel drugs: how do they work?

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Neprilysin as a heart failure biomarker: addressing challenges and exploring new directions
19 May 2025
thumbnail
Congress Presentation
Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs
29 August 2022
thumbnail
Congress Presentation
Effect of neprilysin inhibition on blood urea nitrogen creatinine ratio in HFrEF : comparison of the solvd and paradigm-hf trials
21 May 2023
thumbnail
Congress Presentation
Elevated plasma amyloid, tau and neurofilament light chain suggest high prevalence of ongoing neurodegenerative processes in HFrEF and are linked to worse survival
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources